{"ticker": {"uuid": "ad0ff619-9cc3-4336-bda5-251a1ea3bbda", "symbol": "CDIO", "name": "Cardio Diagnostics Holdings Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "What's Driving Cardio Diagnostics Holdings' Recent Stock Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPRVJlMkRiclNiUllhcEM3R0hieGdlZEJUaEFzR3l5SmwzNER3WmFJbzFCSk9CYVpUUHVuMDJGTjdhRkZyVm11VzlBUUhpN2UwLTZSTEY3cUpGQmFlaHUyakxBWE5NNmFBUVdQaGxGd2thMFNucEgweVdRd2xaWmZkb3BFeFdMSzFBWDZnY21JRVo2MDRrM29DakdhUlo?oc=5", "source_name": "Kavout | AI", "published_at": "2026-07-16T09:39:10+00:00", "published_display": "16 Jul 2026 09:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIOW", "summary": "This article provides the \"Price to book forward\" for Cardio Diagnostics Holdings Inc. (NASDAQ:CDIOW) and highlights that the market was closed with no trades. It also mentions that market data is provided by ICE Data Services and FactSet, with SEC filings from Quartr.", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIOW/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-14T04:41:50", "published_display": "14 Jul 2026 04:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics (NASDAQ: CDIO) eyes private share issuance of up to $10M", "summary": "Cardio Diagnostics Holdings, Inc. (CDIO) is seeking shareholder approval for a 2026 Issuance Proposal to issue up to 5.0 million shares of common stock, or equivalents, for up to $10.0 million in non-public financings. This proposal aims to provide the company with an alternative", "url": "https://www.stocktitan.net/sec-filings/CDIO/pre-14a-cardio-diagnostics-holdings-inc-preliminary-proxy-statement-65a6fb4dab8a.html", "source_name": "Stock Titan", "published_at": "2026-07-13T20:40:45", "published_display": "13 Jul 2026 20:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIOW", "summary": "The article provides a financial snapshot for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIOW), specifically focusing on its forward price-to-earnings ratio. It emphasizes that this data is subject to various market data and reference data providers. The page itself serves as a d", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIOW/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-13T15:40:45", "published_display": "13 Jul 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Enterprise value to EBIT forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIOW", "summary": "The article discusses the enterprise value to EBIT forward for Cardio Diagnostics Holdings Inc., traded on NASDAQ under the symbol CDIOW. It appears to be a financial data page from TradingView, focusing on key financial metrics for the company. The content primarily lists and li", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIOW/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T01:10:43", "published_display": "10 Jul 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIO", "summary": "This article provides financial information for Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO), specifically displaying its enterprise value to revenue (forward) data. The content is presented within the TradingView platform's market data interface, focusing on key financial metr", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIO/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T11:13:50", "published_display": "06 Jul 2026 11:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIO", "summary": "This article provides a brief financial overview for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO), specifically focusing on its forward price-to-earnings ratio. The content appears to be a stub or an introductory page from TradingView, indicating where users might find this fi", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIO/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T12:13:01", "published_display": "05 Jul 2026 12:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIO", "summary": "This article provides the enterprise value to EBIT forward for Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO) as displayed on TradingView. It indicates that the market was closed with no trades at the time of publication and offers various navigational options within the TradingV", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIO/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T00:40:00", "published_display": "05 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIO", "summary": "This article presents financial data, specifically the \"Price to sales forward,\" for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO). It is presented within a TradingView context, indicating stock market data and financial analysis. The content is primarily a data point for the s", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIO/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T11:10:40", "published_display": "03 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIO", "summary": "This article displays the \"Price to book forward\" financial metric for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) on TradingView. It appears to be a stub or a section of a larger financial data display, indicating no specific value or change in the metric at the time of publ", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIO/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T06:10:06", "published_display": "03 Jul 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics (CDIO) director granted 2,854 stock options at $2.19 strike price", "summary": "Cardio Diagnostics Holdings director James Intrater was granted 2,854 stock options at a strike price of $2.19 per share, expiring on June 30, 2036. This grant increases his total direct holdings to options for 13,318 shares. The transaction was reported on July 2, 2026, and is p", "url": "https://www.stocktitan.net/sec-filings/CDIO/form-4-cardio-diagnostics-holdings-inc-insider-trading-activity-fb650a558e43.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:10:06", "published_display": "02 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Cardio Diagnostics Holdings Inc For: 2 July By Investing.com", "summary": "This article reports on a Form 4 filing for Cardio Diagnostics Holdings Inc. on July 2. It appears to be a standard financial news brief announcing the availability of SEC filing information for the company. The content also briefly mentions the company's stock symbol, CDIO, alon", "url": "https://ca.investing.com/news/stock-market-news/form-4-cardio-diagnostics-holdings-inc-for-2-july-93CH-4718663", "source_name": "Investing.com Canada", "published_at": "2026-07-02T16:40:03", "published_display": "02 Jul 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19 strike", "summary": "Peter K. Fung, a director at Cardio Diagnostics Holdings, Inc. (CDIO), was granted 2,854 stock options on June 30, 2026, with an exercise price of $2.19 per share. These options are part of his compensation, granting him the right to purchase shares, and will expire in 2036. Foll", "url": "https://www.stocktitan.net/sec-filings/CDIO/form-4-cardio-diagnostics-holdings-inc-insider-trading-activity-40bc99fd2f0a.html", "source_name": "Stock Titan", "published_at": "2026-07-02T16:40:03", "published_display": "02 Jul 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19", "summary": "Cardio Diagnostics Holdings director Burton Paul Frederick was granted 2,854 stock options with an exercise price of $2.19 per share, expiring on June 30, 2036. This award is part of his equity-based compensation and increases his direct holdings to 13,318 stock options. The Form", "url": "https://www.stocktitan.net/sec-filings/CDIO/form-4-cardio-diagnostics-holdings-inc-insider-trading-activity-d984617c3896.html", "source_name": "Stock Titan", "published_at": "2026-07-02T16:40:03", "published_display": "02 Jul 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics (NASDAQ: CDIO) director awarded 2,854 options at $2.19", "summary": "Cardio Diagnostics Holdings, Inc. director Wendy J. Betts was granted 2,854 stock options with an exercise price of $2.19 per share, expiring on June 30, 2036. This compensation-related award increases her directly held stock options to a total of 12,367 underlying shares. The tr", "url": "https://www.stocktitan.net/sec-filings/CDIO/form-4-cardio-diagnostics-holdings-inc-insider-trading-activity-0403271633e0.html", "source_name": "Stock Titan", "published_at": "2026-07-02T16:40:03", "published_display": "02 Jul 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans", "summary": "Cardio Diagnostics Holdings (CDIO), a precision cardiovascular medicine company, has highlighted its innovative approaches to cardiovascular disease prevention and risk assessment at recent national benefits conferences. The company emphasizes that earlier identification of cardi", "url": "https://www.newmediawire.com/news/cardio-diagnostics-holdings-cdio-showcases-precision-cardiovascular-solutions-for-employers-health-plans-7087457", "source_name": "NewMediaWire", "published_at": "2026-07-01T18:10:04", "published_display": "01 Jul 2026 18:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks", "summary": "Cardio Diagnostics Holdings (CDIO) is utilizing epigenetics to identify hidden heart disease risks, moving beyond traditional genetic assessments. The company emphasizes that epigenetics, which studies how gene expression is regulated without altering the DNA sequence, offers val", "url": "https://finance.yahoo.com/healthcare/articles/cardio-diagnostics-holdings-cdio-leverages-183000218.html", "source_name": "Market source", "published_at": "2026-06-30T18:42:02", "published_display": "30 Jun 2026 18:42", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (NASDAQ: CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans", "summary": "Cardio Diagnostics Holdings (NASDAQ: CDIO), a precision cardiovascular medicine company, recently presented its innovative solutions for cardiovascular disease prevention, risk assessment, and cost management at national benefits conferences. The company emphasizes early identifi", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CDIO-Q/pressreleases/3082228/cardio-diagnostics-holdings-nasdaq-cdio-showcases-precision-cardiovascular-solutions-for-employers-health-plans/", "source_name": "The Globe and Mail", "published_at": "2026-06-30T02:40:46", "published_display": "30 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cardio-diagnostics-holdings-cdio-brings-190000224.html", "source_name": "NewMediaWire", "published_at": "2026-06-29T19:00:00+00:00", "published_display": "29 Jun 2026 19:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings Inc. Actuals & Estimates (NASDAQ:CDIO)", "summary": "This article provides current and historical financial data for Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO), including its stock price, market capitalization, volatility, and net income. It also addresses frequently asked questions about the company's stock performance, future", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIO/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T09:09:24", "published_display": "26 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxOYXhuT3N0ZndvUmZtVHBodTlPaVlEeU5tdWYyY0dHTFJlTTVqQnU3LTRnUTlFRVYtbUsxRHRWZTlzYXFITng4ZDg2WVNScHRZcmlYeFhEeXA3YzZCaC1MLVRJRmNTZFBXWm1yOFdJblozenVSWG1CSUFscERDSEdvS2t0bWZmbXpjbXVNNHlTODFyMzNwVksxUU8yRUxreS1PVXJhV1VZbjlyNEFqbnB6QnEyeTg5Z2YtQVF3V3ZLV2NzUzMyUHhTQU0zVEJ4U2xwdWJKSDhtOEV1T29vVG5DMlZEczY0R29oN0Y1d0gyOEljbFU?oc=5", "source_name": "NewMediaWire", "published_at": "2026-06-25T15:22:07+00:00", "published_display": "25 Jun 2026 15:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians", "summary": "Cardio Diagnostics Holdings announced that Atlas Healthcare Physicians will now cover its Epi+Gen CHD(TM) and PrecisionCHD(TM) tests. This expansion will provide eligible members in Los Angeles and Orange counties with access to these noninvasive, AI-powered precision cardiovascu", "url": "https://www.barchart.com/story/news/2631400/cardio-diagnostics-holdings-nasdaq-cdio-expands-coverage-of-precision-cardiovascular-tests-through-atlas-healthcare-physicians", "source_name": "Barchart.com", "published_at": "2026-06-25T09:10:41", "published_display": "25 Jun 2026 09:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Atlas Healthcare will cover Cardio Diagnostics heart tests for members", "summary": "Cardio Diagnostics Holdings, Inc. announced that Atlas Healthcare Physicians (AHP) will cover its precision cardiovascular medicine tests, Epi+Gen CHD\u2122 and PrecisionCHD\u2122, for members in Southern California starting May 2026. This partnership aims to improve early detection, perso", "url": "https://www.stocktitan.net/news/CDIO/atlas-healthcare-physicians-to-cover-cardio-diagnostics-precision-7632ztr1w5xc.html", "source_name": "Stock Titan", "published_at": "2026-06-24T19:11:20", "published_display": "24 Jun 2026 19:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Atlas Healthcare Physicians to Cover Cardio Diagnostics\u2019 Precision Cardiovascular Medicine Tests Across Its Network", "summary": "Atlas Healthcare Physicians (AHP), an independent physician association in Southern California, will begin covering Cardio Diagnostics\u2019 precision cardiovascular medicine tests, Epi+Gen CHD\u2122 and PrecisionCHD\u2122, for its members in May 2026. This partnership aims to provide physician", "url": "https://www.businesswire.com/news/home/20260624992562/en/Atlas-Healthcare-Physicians-to-Cover-Cardio-Diagnostics-Precision-Cardiovascular-Medicine-Tests-Across-Its-Network", "source_name": "Business Wire", "published_at": "2026-06-24T12:09:31", "published_display": "24 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Company Profile & Introduction", "summary": "This article provides a company profile and introduction to Cardio Diagnostics. Additional details about the company, likely including its operations, mission, and services, would be included in the full document.", "url": "https://www.moomoo.com/stock/CDIO-US/company?chain_id=Name1K9-3FXPhg.1ko2ek0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A33,%22f%22%3A%22mm%2Fnews%2Fpost%2F55945332%2Fgoldman-sachs-adjusts-newmont-price-target-to-62-90-from%22%7D", "source_name": "Moomoo", "published_at": "2026-06-24T11:10:45", "published_display": "24 Jun 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Targets a $393B Heart Disease Problem With Epigenetics and AI", "summary": "Cardio Diagnostics Holdings (CDIO) is addressing the persistent and costly problem of heart disease, the leading cause of death in the US, using an innovative approach combining AI, epigenetics, and genetics. The company aims to detect coronary heart disease earlier and more sens", "url": "https://finance.yahoo.com/healthcare/articles/cardio-diagnostics-holdings-cdio-targets-191000100.html", "source_name": "Market source", "published_at": "2026-06-23T18:41:25", "published_display": "23 Jun 2026 18:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets a $393B Heart Disease Problem with Epigenetics and AI", "summary": "Cardio Diagnostics Holdings (NASDAQ: CDIO) is addressing the significant and growing problem of heart disease, forecasted to incur $1.4 trillion in healthcare costs by 2050, by leveraging epigenetics and AI for early and accurate detection of coronary heart disease. The company's", "url": "https://www.tradingview.com/news/financewire:694c73ae2094b:0-cardio-diagnostics-holdings-nasdaq-cdio-targets-a-393b-heart-disease-problem-with-epigenetics-and-ai/", "source_name": "TradingView", "published_at": "2026-06-23T17:41:25", "published_display": "23 Jun 2026 17:41", "sentiment": "positive", "sentiment_pct": 90, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (NASDAQ: CDIO) Aligns with Growing Shift Toward Predictive, Precision Medicine", "summary": "Cardio Diagnostics Holdings (NASDAQ: CDIO) is advancing personalized cardiovascular care through AI, epigenetics, and genetic insights. The company aims to make prevention more accessible and actionable, aligning with the broader healthcare shift toward predictive and precision m", "url": "https://www.tradingview.com/news/financewire:4b8b84a13094b:0-cardio-diagnostics-holdings-nasdaq-cdio-aligns-with-growing-shift-toward-predictive-precision-medicine/", "source_name": "TradingView", "published_at": "2026-06-23T09:40:03", "published_display": "23 Jun 2026 09:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics (CDIO) Harnesses AI, Genetics and Epigenetics to Advance Cardiovascular Risk Detection", "summary": "Cardio Diagnostics (CDIO) is utilizing artificial intelligence, genetics, and epigenetics to enhance cardiovascular risk detection and management. The company offers solutions like Epi+Gen CHD(TM), PrecisionCHD(TM), HeartRisk(TM), and CardioInnovate360(TM) to address cardiovascul", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cardio-diagnostics-cdio-harnesses-ai-181500211.html", "source_name": "Market source", "published_at": "2026-06-19T13:09:55", "published_display": "19 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Aligns With Growing Shift Toward Predictive, Precision Medicine", "summary": "Cardio Diagnostics Holdings (CDIO) focuses on personalized cardiovascular care using AI, epigenetics, and genetic insights to provide predictive and precision medicine. The company aims to make prevention more accessible and scalable, aligning with a broader healthcare industry s", "url": "https://www.newmediawire.com/news/cardio-diagnostics-holdings-cdio-aligns-with-growing-shift-toward-predictive-precision-medicine-7087229", "source_name": "NewMediaWire", "published_at": "2026-06-19T05:09:49", "published_display": "19 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 90, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings Inc (CDIO) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9Ud1ZHYkh3bm50N3ZpbEhJQnczRGh4ZDI1TnludHhza2ttWl9xSEZPeVlvdEFveXhGR2xsOXVKWHZuREVlZllGOXZ6T1d3MllyT3RDQmpHNmI5WlVLNG5SUjBKZU9teGtLZ21mZ01HLVBzSHhWTFdXMg?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:05:32+00:00", "published_display": "18 Jun 2026 01:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Working to Help Employers Tackle Cardiovascular Risk, Healthcare Costs", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cardio-diagnostics-holdings-cdio-working-190000609.html", "source_name": "NewMediaWire", "published_at": "2026-06-17T19:00:00+00:00", "published_display": "17 Jun 2026 19:00", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Showcases AI-Powered Cardiovascular Risk Solutions at Four National Benefits Conferences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cardio-diagnostics-holdings-cdio-showcases-190000128.html", "source_name": "NewMediaWire", "published_at": "2026-05-27T19:00:00+00:00", "published_display": "27 May 2026 19:00", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cardio Diagnostics to Host Investor Call on AI-Driven Cardiovascular Platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNR3p6WmEzVmpsUUtVelFBU2h0bjUwZlFmNTZqRU53OUJua0FNYXBfcm9jazV3OHZDTjA4aFNpcGdST2N4WVBiODQzTUg5dExTejJTMHhZdWpsRXAxbDd2MjdoNWJOOGJPa3RHbVNKemJZRzliVnpvOXdqZHBGN2dSYi1LQjJUUXFz?oc=5", "source_name": "StocksToTrade", "published_at": "2026-03-01T08:00:00+00:00", "published_display": "01 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Unveils New AI-driven Platform as Market Anticipates Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxOMEJOVmROcUp2dW1Ub2tMMWdWaXNxMC14Z3ZJa2VnX1J5Y25UbEVWc1FUT1BKcUJSazRNT1k4bTZUNU52VUxYajFaNm8xcjVvOXpBU0ZhWmdoMkpuTWVtM1FkbFllX2hIaEZKdzNZbW5mekhvZDhCTC1zVjdXN0ItSDBqX0ZFWTNITVBDVTlOV3o?oc=5", "source_name": "timothysykes.com", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Announces Investor Call Amidst Strategic Growth Plans", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQSmNTVi16d29jQk1DYzY0bV9CcGxROHdUdjhuM090YkJkOUg4bHp2b21wX0tWMFJtQ1UyWEZmYWpjaFd3QzNIN0t4MDRxUHNJVTZWVWhrNFhoU2IzbjdKcjRjZnA1cEhqb2VjZGx0dExOVDdqMmsyOHFXeEVkVzJEX0dmdW9BeC1IYlMxQldVVUdxSGM?oc=5", "source_name": "timothysykes.com", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Prepares for Strategic Investor Call Amid Market Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPVTFLTDl5ZFdVYVE0bllLR20tVUpEQzEtbVVuMV9ZcFRoYWpoMzAyd2stV1BGLWdOOTZwZHo3S3NURHhKV09qeHdYSkNHZXJnOHdwSVhHc2YyMnJ1V3Q1SGRvMjMzVjVOWGxxTXVlcTliQ2hIWUJ5VWUyMHl5OUtDaDFVLTVYQy1oTWROY2xzUVc?oc=5", "source_name": "timothysykes.com", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxORE1SeEM0WkdBVkVxZ0xLWWx2ZzdjVDZwRkYwX3Q3TmNJbTQxTWhOMEU2VzdSa2xaQ0hOd3ZDRWVGTTQycjd0b3k3Tl9pWlZheHdINnBLVkJDVXVwWVFpVlJWOXRnekplaWhIaGt2eHdERFJOVHJMYjRpTVpKcEpHR09KQmNEZ3JkdGdXWEZXWHR5SzJpb2M1SlJIT3ZVRWhJa3A4V2FGNWxIQzdlTkpqemJuVHV2eTQ?oc=5", "source_name": "Stock Titan", "published_at": "2024-10-01T07:00:00+00:00", "published_display": "01 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Cardio Diagnostics (CDIO) Stock Up 45% Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxORTlYUkNFLUNibEtvd09CYkpSa2tTRV9pRFZ6akdKQjlORWZSMkFiYmk0YnlEYkVRSVNNWGhQUk43eFFsVDBxc0g5cUx3QklCQlFUMmwyQzRUd0thN1ptWXllRDVERDlNb1dNSFE1emxDYWtzUmVTb2ZrbWRNX3lLOG4wTUs3ZkdLR2RFcGpRYm51SUYwakE?oc=5", "source_name": "InvestorPlace", "published_at": "2023-10-31T07:00:00+00:00", "published_display": "31 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE5lTFlhTksyd0RnXzR3czNjY21NZmFDV2JOTHNPV25tLWdnUmhKMEZWVnNQUXI3VUYxVmJaVkE2M0FxMTl4c2FZRG1qeTFJQQ?oc=5", "source_name": "Stock Titan", "published_at": "2022-11-09T08:13:46+00:00", "published_display": "09 Nov 2022 08:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mana Capital Acquisition Corp. and Cardio Diagnostics, Inc. Announce Definitive Business Combination Agreement to Create Publicly Listed Company Set to Transform Cardiovascular Disease Through Epigenetics", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Wire", "published_at": "2022-05-31T07:00:00+00:00", "published_display": "31 May 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "What's Driving Cardio Diagnostics Holdings' Recent Stock Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPRVJlMkRiclNiUllhcEM3R0hieGdlZEJUaEFzR3l5SmwzNER3WmFJbzFCSk9CYVpUUHVuMDJGTjdhRkZyVm11VzlBUUhpN2UwLTZSTEY3cUpGQmFlaHUyakxBWE5NNmFBUVdQaGxGd2thMFNucEgweVdRd2xaWmZkb3BFeFdMSzFBWDZnY21JRVo2MDRrM29DakdhUlo?oc=5", "source_name": "Kavout | AI", "published_at": "2026-07-16T09:39:10+00:00", "published_display": "16 Jul 2026 09:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIOW", "summary": "This article provides the \"Price to book forward\" for Cardio Diagnostics Holdings Inc. (NASDAQ:CDIOW) and highlights that the market was closed with no trades. It also mentions that market data is provided by ICE Data Services and FactSet, with SEC filings from Quartr.", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIOW/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-14T04:41:50", "published_display": "14 Jul 2026 04:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics (NASDAQ: CDIO) eyes private share issuance of up to $10M", "summary": "Cardio Diagnostics Holdings, Inc. (CDIO) is seeking shareholder approval for a 2026 Issuance Proposal to issue up to 5.0 million shares of common stock, or equivalents, for up to $10.0 million in non-public financings. This proposal aims to provide the company with an alternative", "url": "https://www.stocktitan.net/sec-filings/CDIO/pre-14a-cardio-diagnostics-holdings-inc-preliminary-proxy-statement-65a6fb4dab8a.html", "source_name": "Stock Titan", "published_at": "2026-07-13T20:40:45", "published_display": "13 Jul 2026 20:40", "sentiment": "negative", "sentiment_pct": 38, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIOW", "summary": "The article provides a financial snapshot for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIOW), specifically focusing on its forward price-to-earnings ratio. It emphasizes that this data is subject to various market data and reference data providers. The page itself serves as a d", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIOW/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-13T15:40:45", "published_display": "13 Jul 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIOW", "summary": "The article discusses the enterprise value to EBIT forward for Cardio Diagnostics Holdings Inc., traded on NASDAQ under the symbol CDIOW. It appears to be a financial data page from TradingView, focusing on key financial metrics for the company. The content primarily lists and li", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIOW/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-10T01:10:43", "published_display": "10 Jul 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIO", "summary": "This article provides financial information for Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO), specifically displaying its enterprise value to revenue (forward) data. The content is presented within the TradingView platform's market data interface, focusing on key financial metr", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIO/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T11:13:50", "published_display": "06 Jul 2026 11:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIO", "summary": "This article provides a brief financial overview for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO), specifically focusing on its forward price-to-earnings ratio. The content appears to be a stub or an introductory page from TradingView, indicating where users might find this fi", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIO/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T12:13:01", "published_display": "05 Jul 2026 12:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIO", "summary": "This article provides the enterprise value to EBIT forward for Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO) as displayed on TradingView. It indicates that the market was closed with no trades at the time of publication and offers various navigational options within the TradingV", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIO/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-05T00:40:00", "published_display": "05 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIO", "summary": "This article presents financial data, specifically the \"Price to sales forward,\" for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO). It is presented within a TradingView context, indicating stock market data and financial analysis. The content is primarily a data point for the s", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIO/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T11:10:40", "published_display": "03 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Cardio Diagnostics Holdings Inc. \u2013 NASDAQ:CDIO", "summary": "This article displays the \"Price to book forward\" financial metric for Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) on TradingView. It appears to be a stub or a section of a larger financial data display, indicating no specific value or change in the metric at the time of publ", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIO/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-03T06:10:06", "published_display": "03 Jul 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics (CDIO) director granted 2,854 stock options at $2.19 strike price", "summary": "Cardio Diagnostics Holdings director James Intrater was granted 2,854 stock options at a strike price of $2.19 per share, expiring on June 30, 2036. This grant increases his total direct holdings to options for 13,318 shares. The transaction was reported on July 2, 2026, and is p", "url": "https://www.stocktitan.net/sec-filings/CDIO/form-4-cardio-diagnostics-holdings-inc-insider-trading-activity-fb650a558e43.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:10:06", "published_display": "02 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Cardio Diagnostics Holdings Inc For: 2 July By Investing.com", "summary": "This article reports on a Form 4 filing for Cardio Diagnostics Holdings Inc. on July 2. It appears to be a standard financial news brief announcing the availability of SEC filing information for the company. The content also briefly mentions the company's stock symbol, CDIO, alon", "url": "https://ca.investing.com/news/stock-market-news/form-4-cardio-diagnostics-holdings-inc-for-2-july-93CH-4718663", "source_name": "Investing.com Canada", "published_at": "2026-07-02T16:40:03", "published_display": "02 Jul 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19 strike", "summary": "Peter K. Fung, a director at Cardio Diagnostics Holdings, Inc. (CDIO), was granted 2,854 stock options on June 30, 2026, with an exercise price of $2.19 per share. These options are part of his compensation, granting him the right to purchase shares, and will expire in 2036. Foll", "url": "https://www.stocktitan.net/sec-filings/CDIO/form-4-cardio-diagnostics-holdings-inc-insider-trading-activity-40bc99fd2f0a.html", "source_name": "Stock Titan", "published_at": "2026-07-02T16:40:03", "published_display": "02 Jul 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19", "summary": "Cardio Diagnostics Holdings director Burton Paul Frederick was granted 2,854 stock options with an exercise price of $2.19 per share, expiring on June 30, 2036. This award is part of his equity-based compensation and increases his direct holdings to 13,318 stock options. The Form", "url": "https://www.stocktitan.net/sec-filings/CDIO/form-4-cardio-diagnostics-holdings-inc-insider-trading-activity-d984617c3896.html", "source_name": "Stock Titan", "published_at": "2026-07-02T16:40:03", "published_display": "02 Jul 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics (NASDAQ: CDIO) director awarded 2,854 options at $2.19", "summary": "Cardio Diagnostics Holdings, Inc. director Wendy J. Betts was granted 2,854 stock options with an exercise price of $2.19 per share, expiring on June 30, 2036. This compensation-related award increases her directly held stock options to a total of 12,367 underlying shares. The tr", "url": "https://www.stocktitan.net/sec-filings/CDIO/form-4-cardio-diagnostics-holdings-inc-insider-trading-activity-0403271633e0.html", "source_name": "Stock Titan", "published_at": "2026-07-02T16:40:03", "published_display": "02 Jul 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans", "summary": "Cardio Diagnostics Holdings (CDIO), a precision cardiovascular medicine company, has highlighted its innovative approaches to cardiovascular disease prevention and risk assessment at recent national benefits conferences. The company emphasizes that earlier identification of cardi", "url": "https://www.newmediawire.com/news/cardio-diagnostics-holdings-cdio-showcases-precision-cardiovascular-solutions-for-employers-health-plans-7087457", "source_name": "NewMediaWire", "published_at": "2026-07-01T18:10:04", "published_display": "01 Jul 2026 18:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks", "summary": "Cardio Diagnostics Holdings (CDIO) is utilizing epigenetics to identify hidden heart disease risks, moving beyond traditional genetic assessments. The company emphasizes that epigenetics, which studies how gene expression is regulated without altering the DNA sequence, offers val", "url": "https://finance.yahoo.com/healthcare/articles/cardio-diagnostics-holdings-cdio-leverages-183000218.html", "source_name": "Market source", "published_at": "2026-06-30T18:42:02", "published_display": "30 Jun 2026 18:42", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (NASDAQ: CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans", "summary": "Cardio Diagnostics Holdings (NASDAQ: CDIO), a precision cardiovascular medicine company, recently presented its innovative solutions for cardiovascular disease prevention, risk assessment, and cost management at national benefits conferences. The company emphasizes early identifi", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CDIO-Q/pressreleases/3082228/cardio-diagnostics-holdings-nasdaq-cdio-showcases-precision-cardiovascular-solutions-for-employers-health-plans/", "source_name": "The Globe and Mail", "published_at": "2026-06-30T02:40:46", "published_display": "30 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cardio-diagnostics-holdings-cdio-brings-190000224.html", "source_name": "NewMediaWire", "published_at": "2026-06-29T19:00:00+00:00", "published_display": "29 Jun 2026 19:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings Inc. Actuals & Estimates (NASDAQ:CDIO)", "summary": "This article provides current and historical financial data for Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO), including its stock price, market capitalization, volatility, and net income. It also addresses frequently asked questions about the company's stock performance, future", "url": "https://www.tradingview.com/symbols/NASDAQ-CDIO/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T09:09:24", "published_display": "26 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8wFBVV95cUxOYXhuT3N0ZndvUmZtVHBodTlPaVlEeU5tdWYyY0dHTFJlTTVqQnU3LTRnUTlFRVYtbUsxRHRWZTlzYXFITng4ZDg2WVNScHRZcmlYeFhEeXA3YzZCaC1MLVRJRmNTZFBXWm1yOFdJblozenVSWG1CSUFscERDSEdvS2t0bWZmbXpjbXVNNHlTODFyMzNwVksxUU8yRUxreS1PVXJhV1VZbjlyNEFqbnB6QnEyeTg5Z2YtQVF3V3ZLV2NzUzMyUHhTQU0zVEJ4U2xwdWJKSDhtOEV1T29vVG5DMlZEczY0R29oN0Y1d0gyOEljbFU?oc=5", "source_name": "NewMediaWire", "published_at": "2026-06-25T15:22:07+00:00", "published_display": "25 Jun 2026 15:22", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (NASDAQ: CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians", "summary": "Cardio Diagnostics Holdings announced that Atlas Healthcare Physicians will now cover its Epi+Gen CHD(TM) and PrecisionCHD(TM) tests. This expansion will provide eligible members in Los Angeles and Orange counties with access to these noninvasive, AI-powered precision cardiovascu", "url": "https://www.barchart.com/story/news/2631400/cardio-diagnostics-holdings-nasdaq-cdio-expands-coverage-of-precision-cardiovascular-tests-through-atlas-healthcare-physicians", "source_name": "Barchart.com", "published_at": "2026-06-25T09:10:41", "published_display": "25 Jun 2026 09:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Atlas Healthcare will cover Cardio Diagnostics heart tests for members", "summary": "Cardio Diagnostics Holdings, Inc. announced that Atlas Healthcare Physicians (AHP) will cover its precision cardiovascular medicine tests, Epi+Gen CHD\u2122 and PrecisionCHD\u2122, for members in Southern California starting May 2026. This partnership aims to improve early detection, perso", "url": "https://www.stocktitan.net/news/CDIO/atlas-healthcare-physicians-to-cover-cardio-diagnostics-precision-7632ztr1w5xc.html", "source_name": "Stock Titan", "published_at": "2026-06-24T19:11:20", "published_display": "24 Jun 2026 19:11", "sentiment": "positive", "sentiment_pct": 70, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Atlas Healthcare Physicians to Cover Cardio Diagnostics\u2019 Precision Cardiovascular Medicine Tests Across Its Network", "summary": "Atlas Healthcare Physicians (AHP), an independent physician association in Southern California, will begin covering Cardio Diagnostics\u2019 precision cardiovascular medicine tests, Epi+Gen CHD\u2122 and PrecisionCHD\u2122, for its members in May 2026. This partnership aims to provide physician", "url": "https://www.businesswire.com/news/home/20260624992562/en/Atlas-Healthcare-Physicians-to-Cover-Cardio-Diagnostics-Precision-Cardiovascular-Medicine-Tests-Across-Its-Network", "source_name": "Business Wire", "published_at": "2026-06-24T12:09:31", "published_display": "24 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Company Profile & Introduction", "summary": "This article provides a company profile and introduction to Cardio Diagnostics. Additional details about the company, likely including its operations, mission, and services, would be included in the full document.", "url": "https://www.moomoo.com/stock/CDIO-US/company?chain_id=Name1K9-3FXPhg.1ko2ek0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A33,%22f%22%3A%22mm%2Fnews%2Fpost%2F55945332%2Fgoldman-sachs-adjusts-newmont-price-target-to-62-90-from%22%7D", "source_name": "Moomoo", "published_at": "2026-06-24T11:10:45", "published_display": "24 Jun 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Targets a $393B Heart Disease Problem With Epigenetics and AI", "summary": "Cardio Diagnostics Holdings (CDIO) is addressing the persistent and costly problem of heart disease, the leading cause of death in the US, using an innovative approach combining AI, epigenetics, and genetics. The company aims to detect coronary heart disease earlier and more sens", "url": "https://finance.yahoo.com/healthcare/articles/cardio-diagnostics-holdings-cdio-targets-191000100.html", "source_name": "Market source", "published_at": "2026-06-23T18:41:25", "published_display": "23 Jun 2026 18:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets a $393B Heart Disease Problem with Epigenetics and AI", "summary": "Cardio Diagnostics Holdings (NASDAQ: CDIO) is addressing the significant and growing problem of heart disease, forecasted to incur $1.4 trillion in healthcare costs by 2050, by leveraging epigenetics and AI for early and accurate detection of coronary heart disease. The company's", "url": "https://www.tradingview.com/news/financewire:694c73ae2094b:0-cardio-diagnostics-holdings-nasdaq-cdio-targets-a-393b-heart-disease-problem-with-epigenetics-and-ai/", "source_name": "TradingView", "published_at": "2026-06-23T17:41:25", "published_display": "23 Jun 2026 17:41", "sentiment": "positive", "sentiment_pct": 90, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (NASDAQ: CDIO) Aligns with Growing Shift Toward Predictive, Precision Medicine", "summary": "Cardio Diagnostics Holdings (NASDAQ: CDIO) is advancing personalized cardiovascular care through AI, epigenetics, and genetic insights. The company aims to make prevention more accessible and actionable, aligning with the broader healthcare shift toward predictive and precision m", "url": "https://www.tradingview.com/news/financewire:4b8b84a13094b:0-cardio-diagnostics-holdings-nasdaq-cdio-aligns-with-growing-shift-toward-predictive-precision-medicine/", "source_name": "TradingView", "published_at": "2026-06-23T09:40:03", "published_display": "23 Jun 2026 09:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics (CDIO) Harnesses AI, Genetics and Epigenetics to Advance Cardiovascular Risk Detection", "summary": "Cardio Diagnostics (CDIO) is utilizing artificial intelligence, genetics, and epigenetics to enhance cardiovascular risk detection and management. The company offers solutions like Epi+Gen CHD(TM), PrecisionCHD(TM), HeartRisk(TM), and CardioInnovate360(TM) to address cardiovascul", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cardio-diagnostics-cdio-harnesses-ai-181500211.html", "source_name": "Market source", "published_at": "2026-06-19T13:09:55", "published_display": "19 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Aligns With Growing Shift Toward Predictive, Precision Medicine", "summary": "Cardio Diagnostics Holdings (CDIO) focuses on personalized cardiovascular care using AI, epigenetics, and genetic insights to provide predictive and precision medicine. The company aims to make prevention more accessible and scalable, aligning with a broader healthcare industry s", "url": "https://www.newmediawire.com/news/cardio-diagnostics-holdings-cdio-aligns-with-growing-shift-toward-predictive-precision-medicine-7087229", "source_name": "NewMediaWire", "published_at": "2026-06-19T05:09:49", "published_display": "19 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 90, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings Inc (CDIO) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMieEFVX3lxTE9Ud1ZHYkh3bm50N3ZpbEhJQnczRGh4ZDI1TnludHhza2ttWl9xSEZPeVlvdEFveXhGR2xsOXVKWHZuREVlZllGOXZ6T1d3MllyT3RDQmpHNmI5WlVLNG5SUjBKZU9teGtLZ21mZ01HLVBzSHhWTFdXMg?oc=5", "source_name": "TradingKey", "published_at": "2026-06-18T01:05:32+00:00", "published_display": "18 Jun 2026 01:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Working to Help Employers Tackle Cardiovascular Risk, Healthcare Costs", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cardio-diagnostics-holdings-cdio-working-190000609.html", "source_name": "NewMediaWire", "published_at": "2026-06-17T19:00:00+00:00", "published_display": "17 Jun 2026 19:00", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Showcases AI-Powered Cardiovascular Risk Solutions at Four National Benefits Conferences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cardio-diagnostics-holdings-cdio-showcases-190000128.html", "source_name": "NewMediaWire", "published_at": "2026-05-27T19:00:00+00:00", "published_display": "27 May 2026 19:00", "sentiment": "negative", "sentiment_pct": 42, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics to Host Investor Call on AI-Driven Cardiovascular Platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNR3p6WmEzVmpsUUtVelFBU2h0bjUwZlFmNTZqRU53OUJua0FNYXBfcm9jazV3OHZDTjA4aFNpcGdST2N4WVBiODQzTUg5dExTejJTMHhZdWpsRXAxbDd2MjdoNWJOOGJPa3RHbVNKemJZRzliVnpvOXdqZHBGN2dSYi1LQjJUUXFz?oc=5", "source_name": "StocksToTrade", "published_at": "2026-03-01T08:00:00+00:00", "published_display": "01 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Unveils New AI-driven Platform as Market Anticipates Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxOMEJOVmROcUp2dW1Ub2tMMWdWaXNxMC14Z3ZJa2VnX1J5Y25UbEVWc1FUT1BKcUJSazRNT1k4bTZUNU52VUxYajFaNm8xcjVvOXpBU0ZhWmdoMkpuTWVtM1FkbFllX2hIaEZKdzNZbW5mekhvZDhCTC1zVjdXN0ItSDBqX0ZFWTNITVBDVTlOV3o?oc=5", "source_name": "timothysykes.com", "published_at": "2026-02-20T08:00:00+00:00", "published_display": "20 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Announces Investor Call Amidst Strategic Growth Plans", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQSmNTVi16d29jQk1DYzY0bV9CcGxROHdUdjhuM090YkJkOUg4bHp2b21wX0tWMFJtQ1UyWEZmYWpjaFd3QzNIN0t4MDRxUHNJVTZWVWhrNFhoU2IzbjdKcjRjZnA1cEhqb2VjZGx0dExOVDdqMmsyOHFXeEVkVzJEX0dmdW9BeC1IYlMxQldVVUdxSGM?oc=5", "source_name": "timothysykes.com", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Prepares for Strategic Investor Call Amid Market Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPVTFLTDl5ZFdVYVE0bllLR20tVUpEQzEtbVVuMV9ZcFRoYWpoMzAyd2stV1BGLWdOOTZwZHo3S3NURHhKV09qeHdYSkNHZXJnOHdwSVhHc2YyMnJ1V3Q1SGRvMjMzVjVOWGxxTXVlcTliQ2hIWUJ5VWUyMHl5OUtDaDFVLTVYQy1oTWROY2xzUVc?oc=5", "source_name": "timothysykes.com", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxORE1SeEM0WkdBVkVxZ0xLWWx2ZzdjVDZwRkYwX3Q3TmNJbTQxTWhOMEU2VzdSa2xaQ0hOd3ZDRWVGTTQycjd0b3k3Tl9pWlZheHdINnBLVkJDVXVwWVFpVlJWOXRnekplaWhIaGt2eHdERFJOVHJMYjRpTVpKcEpHR09KQmNEZ3JkdGdXWEZXWHR5SzJpb2M1SlJIT3ZVRWhJa3A4V2FGNWxIQzdlTkpqemJuVHV2eTQ?oc=5", "source_name": "Stock Titan", "published_at": "2024-10-01T07:00:00+00:00", "published_display": "01 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Cardio Diagnostics (CDIO) Stock Up 45% Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxORTlYUkNFLUNibEtvd09CYkpSa2tTRV9pRFZ6akdKQjlORWZSMkFiYmk0YnlEYkVRSVNNWGhQUk43eFFsVDBxc0g5cUx3QklCQlFUMmwyQzRUd0thN1ptWXllRDVERDlNb1dNSFE1emxDYWtzUmVTb2ZrbWRNX3lLOG4wTUs3ZkdLR2RFcGpRYm51SUYwakE?oc=5", "source_name": "InvestorPlace", "published_at": "2023-10-31T07:00:00+00:00", "published_display": "31 Oct 2023 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cardio Diagnostics Holdings (CDIO) Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE5lTFlhTksyd0RnXzR3czNjY21NZmFDV2JOTHNPV25tLWdnUmhKMEZWVnNQUXI3VUYxVmJaVkE2M0FxMTl4c2FZRG1qeTFJQQ?oc=5", "source_name": "Stock Titan", "published_at": "2022-11-09T08:13:46+00:00", "published_display": "09 Nov 2022 08:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mana Capital Acquisition Corp. and Cardio Diagnostics, Inc. Announce Definitive Business Combination Agreement to Create Publicly Listed Company Set to Transform Cardiovascular Disease Through Epigenetics", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Wire", "published_at": "2022-05-31T07:00:00+00:00", "published_display": "31 May 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 89, "total_relevant": 49, "sentiment_summary": {"positive": 15, "negative": 4, "neutral": 30, "score": 57, "total": 49, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 18.7, "count": 34}, {"event": "earnings", "label": "Earnings", "weight": 4.95, "count": 11}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 15, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 1.72, "latest_week": "2026-07-17", "one_week_move": -6.0, "four_week_move": -13.1, "twelve_week_move": -5.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.438814, "market_dynamics_buy_signal": false, "relative_strength": -47.580884, "fair_value_gap": -89.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.6128, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.0% over one week, -13.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 68, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 11}, {"label": "Market source", "count": 9}, {"label": "Stock Titan", "count": 8}, {"label": "NewMediaWire", "count": 6}, {"label": "timothysykes.com", "count": 3}, {"label": "Business Wire", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Kavout | AI", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 41}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 34}, {"label": "Earnings", "count": 11}, {"label": "Deals and strategy", "count": 3}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "41", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-6.0% over one week, -13.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "What's Driving Cardio Diagnostics Holdings' Recent Stock Surge"}], "updated_at": "2026-07-18T12:18:56.348894+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}